Ramon Eritja
Overview
Explore the profile of Ramon Eritja including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
224
Citations
1729
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Genna V, Portella G, Sala A, Terrazas M, Serrano-Chacon I, Gonzalez J, et al.
Nucleic Acids Res
. 2025 Mar;
53(5).
PMID: 40071936
By combining in silico, biophysical, and in vitro experiments, we decipher the topology, physical, and potential biological properties of hybrid-parallel nucleic acids triplexes, an elusive structure at the basis of...
2.
Clua A, Fabrega C, Musumeci D, Doria F, Pirota V, Ghirga F, et al.
Bioorg Chem
. 2025 Feb;
157:108299.
PMID: 40015110
Lack of specificity towards cancer cells is a major drawback of most chemotherapeutic agents. The use of selective drug delivery systems capable of targeting cancer cells is a valuable perspective...
3.
Hatamli K, Eritja R, Gimenez E, Benavente F, Gargallo R
Talanta
. 2025 Feb;
288:127616.
PMID: 39933343
Triplex DNA structures, which are formed by the addition of an extra strand to a target B-DNA duplex, have attracted increasing interest due to their analytical and therapeutic applications. These...
4.
Poyato C, Pacheco J, Dominguez A, Eritja R, Avino A, Gargallo R
Spectrochim Acta A Mol Biomol Spectrosc
. 2024 Dec;
329():125567.
PMID: 39671818
In this work, strategies for the detection of pyrimidine-rich DNA target sequences based on the formation of duplex and antiparallel triplex structures are studied. The presence of the target is...
5.
Fabrega C, Gallisa-Sune N, Zuin A, Ruiz J, Coll-Martinez B, Fabrias G, et al.
Cells
. 2024 Nov;
13(21.
PMID: 39513874
The development of novel tools to tackle viral processes has become a central focus in global health, during the COVID-19 pandemic. The spike protein is currently one of the main...
6.
Ciudad C, Valiuska S, Rojas J, Nogales-Altozano P, Avino A, Eritja R, et al.
J Biol Chem
. 2024 Oct;
300(11):107884.
PMID: 39395809
Although the COVID-19 pandemic was declared no longer a global emergency by the World Health Organization in May 2023, SARS-CoV-2 is still infecting people across the world. Many therapeutic oligonucleotides...
7.
Mazzini S, Borgonovo G, Princiotto S, Artali R, Musso L, Avino A, et al.
PLoS One
. 2024 Jul;
19(7):e0306239.
PMID: 39046961
Quadruplex-Duplex (Q-D) junctions are unique structural motifs garnering increasing interest as drug targets, due to their frequent occurrence in genomic sequences. The viral HIV LTR-III sequence was chosen as a...
8.
Benigno D, Navarro N, Avino A, Esposito V, Galeone A, Virgilio A, et al.
Eur J Pharm Biopharm
. 2024 Jun;
201:114354.
PMID: 38852755
One of the most appealing approaches for cancer treatment is targeted therapy, which is based on the use of drugs able to target cancer cells without affecting normal ones. This...
9.
Masuku K, Menendez-Mendez L, Noki S, de la Torre B, Albericio F, Fernandez S, et al.
Bioorg Med Chem Lett
. 2024 May;
109:129819.
PMID: 38810710
Oligonucleotides carrying 3'-terminal phosphates and conjugates are important tools in molecular biology and diagnostic purposes. We described the preparation of solid supports carrying the base labile linker 4-((2-hydroxyethyl)sulfonyl)benzamide for the...
10.
Dominguez A, Gargallo R, Cuestas-Ayllon C, Grazu V, Fabrega C, Valiuska S, et al.
Int J Biol Macromol
. 2024 Mar;
264(Pt 1):130540.
PMID: 38430998
Polypyrimidine sequences can be targeted by antiparallel clamps forming triplex structures either for biosensing or therapeutic purposes. Despite its successful implementation, their biophysical properties remain to be elusive. In this...